These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32104447)

  • 1. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein.
    Pi J; Wang S; Li W; Kebebe D; Zhang Y; Zhang B; Qi D; Guo P; Li N; Liu Z
    Asian J Pharm Sci; 2019 Mar; 14(2):154-164. PubMed ID: 32104447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal.
    Li W; Pi J; Zhang Y; Ma X; Zhang B; Wang S; Qi D; Li N; Guo P; Liu Z
    Fitoterapia; 2018 Sep; 129():85-93. PubMed ID: 29936192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
    Huang Y; Zhang B; Gao Y; Zhang J; Shi L
    J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
    Kumar S; Gupta A; Prasad R; Singh S
    Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.
    Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y
    Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
    Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
    Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.
    Karashima M; Sano N; Yamamoto S; Arai Y; Yamamoto K; Amano N; Ikeda Y
    Eur J Pharm Biopharm; 2017 Jun; 115():65-72. PubMed ID: 28223260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenazopyridine-phthalimide nano-cocrystal: Release rate and oral bioavailability enhancement.
    Huang Y; Li JM; Lai ZH; Wu J; Lu TB; Chen JM
    Eur J Pharm Sci; 2017 Nov; 109():581-586. PubMed ID: 28917964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
    Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z
    Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
    Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.
    Zhang J; Lv H; Jiang K; Gao Y
    Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of quercetin-nicotinamide cocrystals and their evaluation under
    Wu N; Zhang Y; Ren J; Zeng A; Liu J
    RSC Adv; 2020 Jun; 10(37):21852-21859. PubMed ID: 35516602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
    Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate.
    Duan C; Liu W; Tao Y; Liang F; Chen Y; Xiao X; Zhang G; Chen Y; Hao C
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
    Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
    Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
    [No Abstract]   [Full Text] [Related]  

  • 17. Chitosan-telmisartan polymeric cocrystals for improving oral absorption: In vitro and in vivo evaluation.
    Ganesh M; Ubaidulla U; Rathnam G; Jang HT
    Int J Biol Macromol; 2019 Jun; 131():879-885. PubMed ID: 30905757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinin Cocrystals for Bioavailability Enhancement. Part 1: Formulation Design and Role of the Polymeric Excipient.
    Kaur M; Yardley V; Wang K; Masania J; Botana A; Arroo RRJ; Li M
    Mol Pharm; 2021 Dec; 18(12):4256-4271. PubMed ID: 34723557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in improving oral drug bioavailability by cocrystals.
    Emami S; Siahi-Shadbad M; Adibkia K; Barzegar-Jalali M
    Bioimpacts; 2018; 8(4):305-320. PubMed ID: 30397585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.